LDTs
How chronic disease creates opportunity on diagnostic and therapeutic pipelines
November 4, 2026Asthma & COPD, Cardiology, Corporate, Diabetes, LDTs, Neurology, Oncology, Osteoporosis, Skin, biomarkers, chronic disease, chronic pain, genetic testing, healthcare innovation, investment
As healthcare budgets become increasingly stretched by the demands of coping with long-term illnesses, interest is growing in the manufacturing …
Latest content
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
